Collagen-based cell migration models in vitro and in vivo.
Fibrillar collagen is the most abundant extracellular matrix (ECM) constituent which maintains the structure of most interstitial tissues and organs, including skin, gut, and breast. Density and spatial alignments of the three-dimensional (3D) collagen architecture define mechanical tissue properties, i.e. stiffness and porosity, which guide or oppose cell migration and positioning in different contexts, such as morphogenesis, regeneration, immune response, and cancer progression. To reproduce interstitial cell movement in vitro with high in vivo fidelity, 3D collagen lattices are being reconstituted from extracted collagen monomers, resulting in the re-assembly of a fibrillar meshwork of defined porosity and stiffness. With a focus on tumor invasion studies, we here evaluate different in vitro collagen-based cell invasion models, employing either pepsinized or non-pepsinized collagen extracts, and compare their structure to connective tissue in vivo, including mouse dermis and mammary gland, chick chorioallantoic membrane (CAM), and human dermis. Using confocal reflection and two-photon-excited second harmonic generation (SHG) microscopy, we here show that, depending on the collagen source, in vitro models yield homogeneous fibrillar texture with a quite narrow range of pore size variation, whereas all in vivo scaffolds comprise a range from low- to high-density fibrillar networks and heterogeneous pore sizes within the same tissue. Future in-depth comparison of structure and physical properties between 3D ECM-based models in vitro and in vivo are mandatory to better understand the mechanisms and limits of interstitial cell movements in distinct tissue environments.
Wolf
Katarina
K
Department of Cell Biology, Nijmegen Center for Molecular Life Science, Radboud University Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. k.wolf@ncmls.ru.nl
Alexander
Stephanie
S
Schacht
Vivien
V
Coussens
Lisa M
LM
von Andrian
Ulrich H
UH
van Rheenen
Jacco
J
Deryugina
Elena
E
Friedl
Peter
P
D000818:Animals; D002465:Cell Movement; D003094:Collagen / Q000737:chemistry / Q000378:metabolism*; D005109:Extracellular Matrix / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology
D003094:Collagen
Cancer Res. 2005 Aug 1;65(15):6543-50
16061633
Cancer Cell. 2008 Mar;13(3):221-34
18328426
Nat Cell Biol. 2007 Aug;9(8):893-904
17618273
J Biomed Mater Res A. 2008 May;85(2):326-35
17688289
J Biol Chem. 1981 Jul 25;256(14):7118-28
7251588
J Exp Med. 1966 Oct 1;124(4):543-56
5922284
Biophys J. 2007 Mar 15;92(6):2212-22
17172303
Nat Med. 2003 Jun;9(6):796-800
12754503
J Vis Exp. 2009 Jun 05;(28):
19578330
Nat Methods. 2008 Dec;5(12):1019-21
18997781
Biophys J. 2008 Oct;95(8):4013-24
18621811
FEBS Lett. 1998 Jan 9;421(2):159-64
9468298
Biophys J. 2002 Jan;82(1 Pt 1):493-508
11751336
J Plast Reconstr Aesthet Surg. 2009 Jun;62(6):849-50
19195956
J Vasc Res. 2003 Sep-Oct;40(5):435-41
14530600
Exp Cell Res. 2006 Nov 1;312(18):3683-92
16978606
Mol Biol Cell. 1999 Oct;10(10):3067-79
10512851
Nat Rev Cancer. 2004 Nov;4(11):839-49
15516957
Cancer Metastasis Rev. 2009 Jun;28(1-2):129-35
19153672
Mol Biol Cell. 2008 Aug;19(8):3221-33
18495869
Nat Cell Biol. 2007 Dec;9(12):1392-400
18037882
Exp Cell Res. 2001 Oct 15;270(1):110-8
11597133
J Cell Sci. 2001 Aug;114(Pt 15):2755-73
11683410
Oncogene. 2006 Sep 21;25(42):5726-40
16652152
J Biomed Mater Res A. 2003 Sep 1;66(3):513-21
12918034
J Mammary Gland Biol Neoplasia. 2006 Apr;11(2):151-63
17106644
J Cell Biol. 2004 Nov 22;167(4):769-81
15557125
BMC Med. 2006 Dec 26;4(1):38
17190588
J Natl Cancer Inst. 1956 Jun;16(6):1375-403
13320119
Microvasc Res. 1973 May;5(3):384-94
4709735
Trends Cell Biol. 2006 Apr;16(4):213-23
16529933
Methods Enzymol. 2008;444:21-41
19007659
J Cell Biol. 1972 Sep;54(3):626-37
4339818
J Cell Biol. 2009 Apr 6;185(1):11-9
19332889
Opt Express. 2008 Feb 4;16(3):1846-59
18542263
Science. 2006 Oct 13;314(5797):298-300
17038622
Curr Opin Biotechnol. 2009 Feb;20(1):54-62
19324541
J Microsc. 2008 Sep;231(3):441-5
18754999
J Invest Dermatol. 2004 Feb;122(2):266-77
15009704
J Exp Med. 1998 Aug 3;188(3):465-74
9687524
J Cell Sci. 2008 Feb 1;121(Pt 3):255-64
18216330
J Mol Biol. 2005 Jun 3;349(2):380-6
15890202
Proc Natl Acad Sci U S A. 1974 Dec;71(12):4826-30
4531019
Histochem Cell Biol. 2008 Dec;130(6):1147-54
18987875
Am J Pathol. 1999 Sep;155(3):739-52
10487832
J Cell Biol. 2003 Jan 20;160(2):267-77
12527751
J Appl Phys. 2009 May 15;105(10):102042
24803683
Biophys J. 2008 Mar 15;94(6):2361-73
18065452
Cancer Res. 1982 May;42(5):1826-37
7066899
Cancer Res. 1997 May 15;57(10):2061-70
9158006
J Cell Biol. 2009 Feb 23;184(4):481-90
19221195
Tissue Eng Part C Methods. 2008 Sep;14(3):261-71
18694322
Cell Mol Life Sci. 2000 Jan 20;57(1):41-64
10949580
Microsc Res Tech. 1998 Dec 1;43(5):369-78
9858334
Histochem Cell Biol. 2008 Dec;130(6):1119-30
19005674
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7075-80
12756303
FASEB J. 1993 Dec;7(15):1434-41
8262328
J Exp Med. 1996 Jul 1;184(1):229-39
8691137
Cancer Res. 2008 May 15;68(10):3671-9
18483249
Res Exp Med (Berl). 1980;177(2):125-34
7003665
Blood. 2003 Nov 1;102(9):3262-9
12855577
Nat Rev Cancer. 2009 Feb;9(2):108-22
19165226
J Mol Biol. 2008 Mar 7;376(5):1509-22
18234220
Cancer Cell. 2005 Sep;8(3):241-54
16169468
AMA Arch Pathol. 1958 Oct;66(4):550-68
13582395
Cancer Res. 1981 May;41(5):1898-904
7214358
Nat Rev Cancer. 2003 Dec;3(12):921-30
14737122
Curr Protoc Cell Biol. 2007 Mar;Chapter 4:Unit 4.15
18228516
Biochem Soc Symp. 2003;(70):277-85
14587300